As of 4:00pm ET
| +0.35 / +2.28%|
The 5 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 24.00, with a high estimate of 33.00 and a low estimate of 21.00. The median estimate represents a +52.67% increase from the last price of 15.72.
The current consensus among 5 polled investment analysts is to Buy stock in Lexicon Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.